Theodore R. Schroeder

Chief Executive Officer, CADENCE PHARMACEUTICALS INC.

Companies

Phathom Pharmaceuticals, Inc.Board member Apr 16, 2025 to now¹
Cidara TherapeuticsBoard member Apr 14, 2015 to now²
Nabriva Therapeutics plcBoard member Feb 4, 2019 to Jan 31, 2023³
Nabriva Therapeutics plcChief executive officer Jul 27, 2018 to Jan 10, 2023⁴
Otonomy (United States)Board member Sep 1, 2015 to Jun 23, 2022⁵
COLLEGIUM PHARMACEUTICAL, INCBoard member Jan 26, 2016 to May 22, 2020⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Phathom Pharmaceuticals, Inc. PHAT45,122 shares⁷$317.0K at $7.03May 19, 2026
Nabriva Therapeutics plc11,989 shares⁸Jan 29, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

May 19, 2026Granted 24,122 shares of Phathom Pharmaceuticals, Inc.⁷
Apr 16, 2025Granted 21,000 shares of Phathom Pharmaceuticals, Inc.⁹
Jan 29, 2023Shares withheld for tax 431 shares at $1.50 of Nabriva Therapeutics plc⁸
Jan 6, 2023Shares withheld for tax 11 shares at $1.30 of Nabriva Therapeutics plc¹⁰
Dec 31, 2022Shares withheld for tax 5 shares at $1.89 of Nabriva Therapeutics plc¹¹
Dec 6, 2022Shares withheld for tax 9 shares at $2.02 of Nabriva Therapeutics plc¹²
Nov 30, 2022Shares withheld for tax 5 shares at $2.25 of Nabriva Therapeutics plc¹³
Nov 6, 2022Shares withheld for tax 10 shares at $2.24 of Nabriva Therapeutics plc¹⁴
Oct 31, 2022Shares withheld for tax 5 shares at $2.54 of Nabriva Therapeutics plc¹⁵
Oct 6, 2022Shares withheld for tax 9 shares at $2.72 of Nabriva Therapeutics plc¹⁶
Sep 30, 2022Shares withheld for tax 5 shares at $2.08 of Nabriva Therapeutics plc¹⁷
Sep 6, 2022Shares withheld for tax 225 shares at $0.16 of Nabriva Therapeutics plc¹⁸
Aug 31, 2022Shares withheld for tax 107 shares at $0.16 of Nabriva Therapeutics plc¹⁹
Aug 6, 2022Shares withheld for tax 225 shares at $0.18 of Nabriva Therapeutics plc²⁰
Jul 31, 2022Shares withheld for tax 107 shares at $0.18 of Nabriva Therapeutics plc²¹
Jul 6, 2022Shares withheld for tax 225 shares at $0.18 of Nabriva Therapeutics plc²²
Jun 30, 2022Shares withheld for tax 107 shares at $0.18 of Nabriva Therapeutics plc²³
Jun 6, 2022Shares withheld for tax 225 shares at $0.20 of Nabriva Therapeutics plc²⁴
May 31, 2022Shares withheld for tax 107 shares at $0.21 of Nabriva Therapeutics plc²⁵
May 6, 2022Shares withheld for tax 225 shares at $0.26 of Nabriva Therapeutics plc²⁶
Apr 30, 2022Shares withheld for tax 107 shares at $0.31 of Nabriva Therapeutics plc²⁷
Apr 6, 2022Shares withheld for tax 219 shares at $0.41 of Nabriva Therapeutics plc²⁸
Mar 31, 2022Shares withheld for tax 104 shares at $0.42 of Nabriva Therapeutics plc²⁹
Mar 6, 2022Shares withheld for tax 263 shares at $0.43 of Nabriva Therapeutics plc³⁰
Feb 28, 2022Shares withheld for tax 125 shares at $0.45 of Nabriva Therapeutics plc³¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPhathom Pharmaceuticals, Inc., Board member
2
SEC EDGARCidara Therapeutics, Board member
3
SEC EDGARNabriva Therapeutics plc, Board member
4
SEC EDGARNabriva Therapeutics plc, Chief executive officer
5
SEC EDGAROtonomy (United States), Board member
6
SEC EDGARCOLLEGIUM PHARMACEUTICAL, INC, Board member
7
SEC EDGARPhathom Pharmaceuticals, Inc. shares after the filing of May 19, 2026
8
SEC EDGARNabriva Therapeutics plc shares after the filing of Jan 29, 2023
9
SEC EDGARForm 4 filed Apr 16, 2025
10
SEC EDGARForm 4 filed Jan 10, 2023
11
SEC EDGARForm 4 filed Jan 4, 2023
12
SEC EDGARForm 4 filed Dec 8, 2022
13
SEC EDGARForm 4 filed Dec 2, 2022
14
SEC EDGARForm 4 filed Nov 8, 2022
15
SEC EDGARForm 4 filed Nov 1, 2022
16
SEC EDGARForm 4 filed Oct 11, 2022
17
SEC EDGARForm 4 filed Oct 4, 2022
18
SEC EDGARForm 4 filed Sep 7, 2022
19
SEC EDGARForm 4 filed Sep 1, 2022
20
SEC EDGARForm 4 filed Aug 8, 2022
21
SEC EDGARForm 4 filed Aug 3, 2022
22
SEC EDGARForm 4 filed Jul 7, 2022
23
SEC EDGARForm 4 filed Jul 1, 2022
24
SEC EDGARForm 4 filed Jun 7, 2022
25
SEC EDGARForm 4 filed Jun 2, 2022
26
SEC EDGARForm 4 filed May 9, 2022
27
SEC EDGARForm 4 filed May 3, 2022
28
SEC EDGARForm 4 filed Apr 8, 2022
29
SEC EDGARForm 4 filed Apr 4, 2022
30
SEC EDGARForm 4 filed Mar 8, 2022
31
SEC EDGARForm 4 filed Mar 2, 2022